Jon E. Angell

Array ( [id] => 6615615 [patent_doc_number] => 20100323922 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-12-23 [patent_title] => 'siRNA targeting TATA box binding protein (TBP)-associated factor (TAF1)' [patent_app_type] => utility [patent_app_number] => 12/806320 [patent_app_country] => US [patent_app_date] => 2010-08-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 43 [patent_figures_cnt] => 43 [patent_no_of_words] => 34764 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0323/20100323922.pdf [firstpage_image] =>[orig_patent_app_number] => 12806320 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7580983 [patent_doc_number] => 20110294866 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-12-01 [patent_title] => 'PHARMACEUTICAL COMPOSITION FOR TREATING DEMENTIA COMPRISING SHRNA INHIBITING S100A9 EXPRESSION' [patent_app_type] => utility [patent_app_number] => 12/851273 [patent_app_country] => US [patent_app_date] => 2010-08-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 5523 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0294/20110294866.pdf [firstpage_image] =>[orig_patent_app_number] => 12851273 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8956240 [patent_doc_number] => 08502015 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2013-08-06 [patent_title] => 'Method of inducing cancer' [patent_app_type] => utility [patent_app_number] => 12/831129 [patent_app_country] => US [patent_app_date] => 2010-07-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 4189 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 43 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12831129 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8277295 [patent_doc_number] => 20120171170 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-07-05 [patent_title] => 'TREATMENT OF COLLAGEN GENE RELATED DISEASES BY INHIBITION OF NATURAL ANTISENSE TRANSCRIPT TO A COLLAGEN GENE' [patent_app_type] => utility [patent_app_number] => 13/377888 [patent_app_country] => US [patent_app_date] => 2010-06-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 28694 [patent_no_of_claims] => 46 [patent_no_of_ind_claims] => 13 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13377888 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8056253 [patent_doc_number] => 20120077867 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-03-29 [patent_title] => 'Compositions And Methods For Treating Pancreatic Cancer' [patent_app_type] => utility [patent_app_number] => 13/376240 [patent_app_country] => US [patent_app_date] => 2010-06-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 6199 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0077/20120077867.pdf [firstpage_image] =>[orig_patent_app_number] => 13376240 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8543399 [patent_doc_number] => 08318691 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-11-27 [patent_title] => 'Treatment of tumors with genetically engineered herpes virus' [patent_app_type] => utility [patent_app_number] => 12/802443 [patent_app_country] => US [patent_app_date] => 2010-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3894 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 69 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12802443 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5978279 [patent_doc_number] => 20110071208 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-03-24 [patent_title] => 'LIPID ENCAPSULATED DICER-SUBSTRATE INTERFERING RNA' [patent_app_type] => utility [patent_app_number] => 12/794701 [patent_app_country] => US [patent_app_date] => 2010-06-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 36138 [patent_no_of_claims] => 34 [patent_no_of_ind_claims] => 15 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0071/20110071208.pdf [firstpage_image] =>[orig_patent_app_number] => 12794701 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9574958 [patent_doc_number] => 08765370 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-07-01 [patent_title] => 'Inhibition-based high-throughput screen strategy for cell clones' [patent_app_type] => utility [patent_app_number] => 12/792924 [patent_app_country] => US [patent_app_date] => 2010-06-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 13 [patent_no_of_words] => 7443 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 61 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12792924 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9574958 [patent_doc_number] => 08765370 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-07-01 [patent_title] => 'Inhibition-based high-throughput screen strategy for cell clones' [patent_app_type] => utility [patent_app_number] => 12/792924 [patent_app_country] => US [patent_app_date] => 2010-06-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 13 [patent_no_of_words] => 7443 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 61 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12792924 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8227810 [patent_doc_number] => 20120142013 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-06-07 [patent_title] => 'NUCLEIC ACID APTAMER CAPABLE OF BINDING SPECIFICALLY TO PANCREATIC CANCER CELLS OR TISSUES AND USE THEREOF' [patent_app_type] => utility [patent_app_number] => 13/375347 [patent_app_country] => US [patent_app_date] => 2010-06-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 21 [patent_no_of_words] => 8879 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13375347 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8571739 [patent_doc_number] => 08338384 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-12-25 [patent_title] => 'Method for treating ocular neovascularization' [patent_app_type] => utility [patent_app_number] => 12/785461 [patent_app_country] => US [patent_app_date] => 2010-05-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11764 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 53 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12785461 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10006875 [patent_doc_number] => 09050373 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-06-09 [patent_title] => 'Pharmaceutical compositions comprising antisense oligonucleotides and methods of using same' [patent_app_type] => utility [patent_app_number] => 12/800376 [patent_app_country] => US [patent_app_date] => 2010-05-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 7071 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 50 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12800376 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6518791 [patent_doc_number] => 20100216982 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-08-26 [patent_title] => 'POLYCYCLIC SUGAR SURROGATE-CONTAINING OLIGOMERIC COMPOUNDS AND COMPOSITIONS FOR USE IN GENE MODULATION' [patent_app_type] => utility [patent_app_number] => 12/774566 [patent_app_country] => US [patent_app_date] => 2010-05-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 37378 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0216/20100216982.pdf [firstpage_image] =>[orig_patent_app_number] => 12774566 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8834717 [patent_doc_number] => 08450473 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-05-28 [patent_title] => 'Compositions and methods for therapy of macular degeneration' [patent_app_type] => utility [patent_app_number] => 13/266219 [patent_app_country] => US [patent_app_date] => 2010-04-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 5915 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 26 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13266219 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6237003 [patent_doc_number] => 20100267815 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-10-21 [patent_title] => 'PFKFB4 Inhibitors And Methods Of Using The Same' [patent_app_type] => utility [patent_app_number] => 12/761773 [patent_app_country] => US [patent_app_date] => 2010-04-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 6515 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0267/20100267815.pdf [firstpage_image] =>[orig_patent_app_number] => 12761773 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6502898 [patent_doc_number] => 20100286362 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-11-11 [patent_title] => 'Mammalian MDM2 Binding Proteins and Uses Thereof' [patent_app_type] => utility [patent_app_number] => 12/759906 [patent_app_country] => US [patent_app_date] => 2010-04-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6201 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0286/20100286362.pdf [firstpage_image] =>[orig_patent_app_number] => 12759906 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8732656 [patent_doc_number] => 20130078225 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-03-28 [patent_title] => 'Method for Modulating MicroRNA Content in Living Beings and the Use Thereof' [patent_app_type] => utility [patent_app_number] => 13/641074 [patent_app_country] => US [patent_app_date] => 2010-04-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 11514 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13641074 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6273295 [patent_doc_number] => 20100255545 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-10-07 [patent_title] => 'INTEGRATED - LIGAND-RESPONSIVE MICRORNAS' [patent_app_type] => utility [patent_app_number] => 12/753778 [patent_app_country] => US [patent_app_date] => 2010-04-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 16544 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0255/20100255545.pdf [firstpage_image] =>[orig_patent_app_number] => 12753778 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6276366 [patent_doc_number] => 20100256219 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-10-07 [patent_title] => 'Small interfering DNA (siDNA) oligonucleotides as an antiviral agent against Herpes virus infections' [patent_app_type] => utility [patent_app_number] => 12/748897 [patent_app_country] => US [patent_app_date] => 2010-03-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 6618 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0256/20100256219.pdf [firstpage_image] =>[orig_patent_app_number] => 12748897 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8772624 [patent_doc_number] => 08426581 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-04-23 [patent_title] => 'RNA interference mediated inhibition of the FCεR1α gene' [patent_app_type] => utility [patent_app_number] => 13/256095 [patent_app_country] => US [patent_app_date] => 2010-03-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 41737 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 14 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13256095 [rel_patent_id] =>[rel_patent_doc_number] =>)